High doses of α-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: Long term results of a prospective randomized trial

American Journal of Gastroenterology

Volumn 96, Issue 10, 2001, Pages 2973-2977

  Villa, Erica ^a   Grottola, Antonella ^a   Buttafoco, Paola ^a   Colantoni, Alessandra ^a   Bagni, Alberto ^a   Ferretti, Ilva ^a   Cremonini, Claudia ^a   Bertani, Helga ^a   Manenti, Federico ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOT HYBRIDIZATION; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0034798778     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03232-4     Document Type: Article

References (24)

1. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection
2. Impact of HBV, HCV, and GBV-C/HGV on hepatocellular carcinomas in Europe. Results of a European concerted action
3. Viral replication in patients with concomitant hepatitis B and C virus infections
4. Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B
5. Hepatitis C contributes to liver disease in children and adolescents with hemophilia
6. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment
7. Impact of interferon-alpha therapy on the development of hepatocellular carcinoma in patients with liver cirrhosis: Results of an international survey
8. Progression of hepatitis B and C to hepatocellular carcinoma in Western countries
9. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis
10. Delayed clearance of serum HbsAg in compensated cirrhosis B: Relation to interferon alpha therapy and disease prognosis
11. Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis
12. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection
13. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis
14. Histological grading and staging of chronic hepatitis
15. Typing of hepatitis C virus by polymerase chain reaction with type specific primers: Application to clinical surveys and tracing infectious sources
16. Multiple hepatitis virus infections in chronic HBsAg carriers in Naples
17. Concurrent hepatitis B, and C virus infection, and risk of hepatocellular carcinoma in cirrhosis. A prospective study
18. Selection of more pathogenic HCV genotype II during long-term follow-up of interferon treated patients
19. Reactivation of hepatitis-B virus infection induced by interferon (IFN) in HBsAg-positive, AntiHCV-positive patients
20. Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus, probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection
21. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B
22. Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study
23. Concurrent hepatitis C virus, and hepatitis delta superinfection in patients with chronic hepatitis B virus infection
24. Hepatitis type C virus infection in patients with type B chronic liver disease